Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Aslan, Tuncay"'
Autor:
Aylin Dizi Işık, Özcan Sönmez, Pınar Canizci Erdemli, Eda Kepenekli, Zeynep Ergenç, Seyhan Yılmaz, Sevgi Aslan Tuncay, Burcu Parlak, Adnan Dağçınar
Publikováno v:
Iranian Journal of Parasitology, Vol 19, Iss 1 (2024)
Introduction: Echinococcosis is the most common cestode infection globally caused by the Echinococcus species. The most common organ involvement is the lungs and liver, but other organs can also be rarely involved. Here, we present a case with a gian
Externí odkaz:
https://doaj.org/article/72230ed77d99415bbaa5688ab451fd14
Autor:
Nurhayat Yakut, Zeynep Ergenc, Sevgi Aslan Tuncay, Sezin Bayraktar, Elvan Sayin, Arzu Ilki, Eda Kepenekli
Publikováno v:
Asian Pacific Journal of Tropical Medicine, Vol 16, Iss 8, Pp 354-362 (2023)
Objective: To describe clinical and epidemiological characteristics, antimicrobial susceptibility and mortality-associated factors of healthcare-associated infections (HCAIs) caused by Staphylococcus (S.) aureus in children. Methods: We conducted a r
Externí odkaz:
https://doaj.org/article/3730488d4cfc45668ca893fb28e1ba1d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aslan, Tuncay, Eroğlu, Serkan Emre, İslam, Mehmet Muzaffer, Özdemir, Serdar, Aksel, Gökhan, Algın, Abdullah
Publikováno v:
Journal of Acute Disease; Sep2023, Vol. 12 Issue 5, p192-197, 6p
Autor:
Okay, Müfide1 mufide_okay@yahoo.com, Aslan, Tuncay1, Özdemir, Evren2, Üner, Ayşegül3, Sağlam, Arzu3, Güngör, Elif4, Uysal, Ayşe5, Aslan, Nevin Alayvaz6, Yıldızhan, Esra7, Ağıt, Abdullah8, Dal, Mehmet Sinan9, Korkmaz, Serdal10, Namdaroğlu, Sinem11, Sivgin, Serdar12, Çağlıyan, Gülsüm Akgün13, Demircioğlu, Sinan14, Barışta, İbrahim15, Özhamam, Esra16, Vural, Filiz17, Eser, Bülent7
Publikováno v:
Turkish Journal of Hematology. 2020, Vol. 37 Issue 2, p84-90. 7p.
Publikováno v:
Turkish Journal of Emergency Medicine, Vol 20, Iss 3, Pp 149-151 (2020)
Turkish Journal of Emergency Medicine
Turkish Journal of Emergency Medicine
Hydroxychloroquine is one of the most commonly used drugs in COVID-19 treatment. In this case report, we aimed to present a young patient whose QT interval was prolonged due to hydroxychloroquine overdose which was given for COVID-19 treatment. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::885db5bfd839d0c75f8b7a48d74d9d00
http://www.turkjemergmed.org/article.asp?issn=2452-2473
http://www.turkjemergmed.org/article.asp?issn=2452-2473
Autor:
Malkan, Umit Yavuz, Gunes, Gursel, Isik, Ayse, Eliacik, Eylem, Etgul, Sezgin, Aslan, Tuncay, Balaban, Muruvvet Seda, Haznedaroglu, Ibrahim Celalettin, Demiroglu, Haluk, Goker, Hakan, Ozcebe, Osman Ilhami, Sayinalp, Nilgun, Aksu, Salih, Buyukasik, Yahya, Mahallesi, Mutlukent
Publikováno v:
Acta Haematologica. 134:32-37
There are very few data about the relationship between acute myeloid leukemia (AML) prognosis and bone marrow recovery kinetics following chemotherapy. In this study, we aimed to assess the prognostic importance and clinical associations of neutrophi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a67a2d8312a9ca3e5c47ce483e9b26f
https://doi.org/10.1159/000369917
https://doi.org/10.1159/000369917
Autor:
Aktimur, Sude H., Malkan, Umit Y., Eyupoglu, Damla N., Haznedaroglu, Ibrahim C., Kelkitli, Engin, Atay, Hilmi M., Gunes, Gursel, Etgul, Sezgin, Aslan, Tuncay, Goker, Hakan, Sayinalp, Nilgun, Aksu, Salih, Ozcebe, Osman I., Buyukasik, Yahya, Turgut, Mehmet
Haznedaroglu, Ibrahim C./0000-0001-8028-9462; aktimur, sude hatun/0000-0002-7468-1721; Malkan, Umit Yavuz/0000-0001-5444-4895 WOS: 000388276400004 Ruxolitinib as a JAK1 and JAK2 inhibitor drug has recently been approved for the treatment of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::510d9908caaf14e6b14f15e7a9b76176
https://hdl.handle.net/20.500.12712/13673
https://hdl.handle.net/20.500.12712/13673
